Delivery Order SPE2DB22D1202-SPE2DB24FVPB3

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a firm-fixed-price of $1,997.88 and a period of performance through November 16, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.81, is for the delivery of 4,568,076,535 units of albuterol HFA 90 mcg inhalers, 8.5 grams each. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albuterol HFA 90mcg inhalers, which are likely medical products used to treat respiratory conditions. The contract has a ceiling value of $2,753.74 and a completion date of June 3, 2025. It is a Firm Fixed Price contract, indicating a pre-determined price for the goods....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.80, is for the delivery of Albuterol HFA 90 MCG inhalers with an ultimate completion date of February 10, 2025. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 mcg inhalers. The contract has a ceiling value of $1,090.59 and a completion date of August 5, 2024. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen has been awarded numerous federal contracts by various agencies, including a $7,570,000 definitive contract with the Office of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG inhalers. The contract has a ceiling value of $2,072.37 and a period of performance through July 31, 2024. It is a firm fixed-price contract without a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,701,704 units of Albuterol HFA 90 MCG Inhalers. The contract has a ceiling value of $2,130.07 and a completion date of July 3, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,850.11 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Albuterol HFA 90mcg inhalers. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the supply of 4,565,860,646 units of Albuterol HFA 90 mcg inhalers, a critical asthma medication, with a ceiling value of $2,342.12. The delivery order is a firm fixed-price contract with a completion date of September 19, 2024. Amerisourcebergen is a large, for-profit organization that holds several Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVPB3
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of albuterol HFA 90 mcg inhalers. The contract is a firm fixed-price Delivery Order with a ceiling value of $2,590.75 and an ultimate completion date of September 19, 2024. The contract has no set-aside designation. As a significant federal contractor, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of critical pharmaceutical and medical supplies to support military treatment facilities, veterans' healthcare, and other federal healthcare programs nationwide.

Generated 12/18/24, 9:14 AM